1. Home
  2. APA vs HALO Comparison

APA vs HALO Comparison

Compare APA & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo APA Corporation

APA

APA Corporation

HOLD

Current Price

$43.77

Market Cap

9.7B

Sector

Energy

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$62.12

Market Cap

8.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APA
HALO
Founded
1954
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
8.8B
IPO Year
2021
2001

Fundamental Metrics

Financial Performance
Metric
APA
HALO
Price
$43.77
$62.12
Analyst Decision
Hold
Buy
Analyst Count
22
11
Target Price
$29.82
$78.18
AVG Volume (30 Days)
9.0M
1.3M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
2.25%
N/A
EPS Growth
75.77
N/A
EPS
3.99
2.56
Revenue
N/A
$151,862,000.00
Revenue This Year
N/A
$28.24
Revenue Next Year
N/A
$12.79
P/E Ratio
$11.14
$24.11
Revenue Growth
N/A
N/A
52 Week Low
$13.58
$47.50
52 Week High
$44.54
$82.22

Technical Indicators

Market Signals
Indicator
APA
HALO
Relative Strength Index (RSI) 83.54 32.28
Support Level $22.73 $61.23
Resistance Level N/A $65.40
Average True Range (ATR) 1.49 1.52
MACD 0.69 -0.01
Stochastic Oscillator 83.52 10.49

Price Performance

Historical Comparison
APA
HALO

About APA APA Corporation

APA Corp is an independent exploration and production company. It develops, and produces crude oil, natural gas, and natural gas liquids. The Company's business has oil and gas operations in three geographic areas: the United States (U.S.), Egypt, and offshore the U.K. in the North Sea (North Sea). APA also has active development, exploration, and appraisal operations ongoing in Suriname, as well as exploration interests in Uruguay, Alaska, and other international locations.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: